CATUG Joins the Superlab Suisse Community as New Residents to Advance R&D Activities

Basel, Switzerland – November 19, 2024 – CATUG, an innovative Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) specializing in RNA and gene therapy as well as lipidic nanocarriers, is pleased to announce that it has joined the Superlab Suisse community at its Basel facilities. This collaboration grants CATUG access to Superlab’s state-of-the-art laboratory facilities, providing the company with essential infrastructure for conducting research and development (R&D) activities aimed at developing intellectual property (IP).

Why Superlab Suisse?

Superlab Suisse is transforming the concept of shared laboratory space by offering scientists access to the tools, space, and flexibility they need to focus entirely on their research. With cutting-edge equipment, specialized facilities, and a thriving ecosystem of innovators, Superlab creates a dynamic environment that promotes collaboration. For CATUG, selecting Superlab Suisse is a strategic opportunity to tap into Basel’s world-renowned pharmaceutical hub and accelerate scientific discovery in a space designed for innovation.

“We are thrilled to collaborate with Superlab Suisse. Their incredible spaces are designed for passionate researchers that want to focus on science in a stimulating and sharing environment,” said Dr. Lin Jin, Co-Founder and President of CATUG. “Located in Basel, a key hub for pharmaceutical advancements in Europe, it provides an ideal setting for our R&D activities. Being part of this community will enable us to conduct local research, develop our company’s intellectual property, and better serve our European clients with tailored scientific services.”

Empowering Innovation

This collaboration marks a significant milestone for CATUG as the company continues its expansion across Europe, focusing on providing advanced solutions in the nucleic acid and nano-delivery space. With a strategic presence at Superlab Suisse, CATUG aims to enhance its R&D capabilities and develop new services to strengthen its offering for both local and international clients.

“CATUG is a startup for startups, built by scientists for scientists, focused on RNA and gene therapy research services,” said Zhang Xi, CEO of Superlab Suisse. “With their expertise, they provide exceptional professional support at every step in science. We're excited to see the impactful research and development they will bring to our shared space.”

This will be CATUG’s first dedicated bench space in Switzerland, and the company plans to actively seek scientists to join its team in Basel as it scales its research operations in the region.

About Superlab Suisse

Superlab Suisse is a shared laboratory space provider with locations in Lausanne, Basel, and Zurich. Offering state-of-the-art lab spaces and cutting-edge equipment, Superlab Suisse supports scientists and startups in advancing biotech, pharmaceutical, and life sciences research. By fostering collaboration and innovation, they empower researchers to focus on their discoveries and accelerate their growth in the heart of Europe's leading life science hubs.

About CATUG

CATUG is a leading biotechnology company specializing in RNA and gene therapy research services. With a vision to revolutionize the biopharmaceutical industry, CATUG is dedicated to advancing scientific discoveries, providing tailored R&D support, and expanding its presence across Europe. As an official member of Superlab Suisse, CATUG reinforces its commitment to fostering innovation in Europe.

For more information, please visit www.catug.bio.